Insider Cluster (2 insiders) ·Filed Mar 4, 2026

WGS

GeneDx Holdings Corp.
BEARISH
Impact 6/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $566K total
Actionable Insight ▼ Bearish

Monitor for potential downward pressure ahead of next earnings or lack of catalysts; consider whether this selling follows a pattern of post-earnings or vesting-date transactions. The CEO's sale is particularly concerning given size and timing relative to grants.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
WGS ▼ -36.89% at T+60d
SHORT call ✓ call won +36.89% · α vs SPY +46.98% · entry $79.47 → $50.15
Entry anchored
Mar 3, 03:59 PM ET
via exchange tick
T+1d
+3.18%
call -3.18% · α -3.76%
$82.00
settled 7mo ago
T+5d
+7.08%
call -7.08% · α -8.42%
$85.10
settled 7mo ago
T+20d
-17.55%
call +17.55% · α +13.14%
$65.52
settled 6mo ago
T+60d
-36.89%
call +36.89% · α +46.98%
$50.15
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

GeneDx CEO Katherine Stueland sold $455K in open-market shares while receiving a large non-cash stock award; CFO Kevin Feeley sold $110K and received non-cash grants. The cluster is dominated by routine compensation grants, but the CEO's open-market sale is the largest transaction and suggests potential lack of conviction.

Key Financial Metrics

Direction
selling
Total Value
$565.5K
Insiders
2

Key Facts

  • CEO Katherine Stueland sold 5,861 shares at $77.63, totaling $454,967 in open-market transaction
  • CFO Kevin Feeley sold 1,424 shares for $110,540 in open-market trade
  • CEO and CFO received substantial non-cash stock awards totaling 107,469 shares collectively, valued at $299,926 for the CEO's time-based grant
  • Total open-market selling: $565,507 (CEO: $455K, CFO: $110.5K)
  • Open-market sales represent ~0.022% of $2.6B market cap — modest but notable given C-suite participation

Financial Impact

$565,507 in net open-market selling by C-suite executives

insider sentimentshareholder confidence

Risk Factors

  • Insider selling may signal lack of confidence in near-term prospects
  • Potential for negative market perception despite routine nature of grants

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (7 trades, 7d window)cluster-WGS-1773057319627
11 reports for WGS
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +63.51%May 20, 2026
Filters
Rows
Reports for WGS — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 2/10
$85.27 $101.10▲ +18.57%▲ +18.79%$73.09 (−14.28%)
Sep 1, 2026
4w ago
144
NEUTRAL ★ 2/10
$86.72 $83.96▼ −3.18%▼ −2.22%$73.09 (−15.72%)
Jul 27, 2026
9w ago
Press Release
BEARISH ★ 7/10
$61.88 $67.86▼ −9.66%▼ −7.39%$73.09 (−18.12%)
Jul 23, 2026
10w ago
Press Release
BEARISH ★ 7/10
$63.38 $68.96▼ −8.80%▼ −8.33%$73.09 (−15.32%)
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$60.60 $58.08▼ −4.16%▼ −1.93%$73.09 (+20.61%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 4/10
$59.92 $59.01▼ −1.52%▼ −2.19%$73.09 (+21.98%)
Jun 8, 2026
16w ago
Insider Cluster
BULLISH ★ 6/10
$56.33 $61.32▲ +8.86%▲ +6.45%$73.09 (+29.75%)
May 20, 2026
19w ago
Insider Cluster
BULLISH ★ 6/10
$47.33 $50.15▲ +5.96%▲ +4.36%$73.09 (+54.43%)
Mar 26, 2026
27w ago
Insider Cluster
BEARISH ★ 6/10
$61.35 $66.20▼ −7.91%▼ −6.27%$73.09 (−19.14%)
Mar 4, 2026
30w ago
Insider Cluster
BEARISH ★ 6/10
$79.47 $85.10▼ −7.08%▼ −8.42%$73.09 (+8.03%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 9, 2026